Related Experiment Video
Updated: May 17, 2026
06:07
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Iron accumulation in Parkinson's disease
Hideki Mochizuki1, Toru Yasuda
1Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. hmochizuki@neurol.med.osaka-u.ac.jp
Journal of Neural Transmission (Vienna, Austria : 1996)
|October 17, 2012
Summary
Iron accumulation in the substantia nigra is linked to Parkinson's disease (PD) pathogenesis. This review explores iron's mechanisms and toxic effects in hereditary and sporadic PD, including animal models.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Parkinson's disease (PD) etiology remains largely unknown.
- Elevated iron levels in the substantia nigra are observed in PD patients.
- Mechanisms of iron accumulation in PD are not fully understood.
Purpose of the Study:
- To review recent findings on iron accumulation mechanisms in PD.
- To discuss the potential toxic effects of iron in PD.
- To examine iron's role in hereditary and sporadic PD, including animal models.
Main Methods:
- Literature review of recent studies on iron in PD.
- Analysis of findings from human PD patients.
- Examination of data from genetic mouse models of PD.
Main Results:
- Significant iron elevation in the substantia nigra is a hallmark of PD.
- Iron accumulation is implicated in nigral cell death.
- Mechanisms of iron dysregulation contribute to PD pathology.
Conclusions:
- Iron accumulation plays a critical role in the pathogenesis of Parkinson's disease.
- Understanding iron's mechanisms is key to developing new PD therapies.
- Further research into iron's role in PD is warranted.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...